Jan 22, 2019 | Clinical Trials, Pharmaceuticals
According to the CDC, 650,000 patients receive chemotherapy every year in the U.S. alone. The side effects are bad enough to cause people to opt into not getting treatment at all. Until now. A new cancer treatment device has been made which reduces the negative... 
Oct 12, 2017 | CFDA, Clinical Trials
Earlier this week, China’s State Council announced plans to allow clinical trial data from other countries. As one of the largest pharmaceutical markets in the world, they are looking to bring in new, innovative therapies quicker. This comes on the heels of...Aug 24, 2017 | Clinical Trials
At DIA in June of this year, Tatsuya Kondo, Chief Executive of Pharmaceuticals and Medical Devices Agency (PMDA) gave a presentation on the future activities of the PMDA in Japan. In the presentation, Kondo discusses Japan’s “Rational Medicine”...Aug 17, 2017 | Clinical Trials, Linguistic Validation
The life science sector is continually evolving and becoming ever more globalized. What used to work as a business model is progressively challenged by cost pressures, operating performance challenges as more mergers and acquisitions take place, and global trends in...Jul 27, 2017 | Clinical Trials, FDA
Beginning in December of last year, all clinical trials are now required to adhere to CDISC Standards. The Clinical Data Interchange Standards Consortium (CDISC) is a global not for profit organization with a mission to develop global standards. Through standardized...Jun 8, 2017 | Clinical Trials
Several years ago, clinical trials in India were a booming business. After becoming fully compliant with TRIPS in 2005, India was seen as a favorable place to conduct clinical trials as they boast a huge genetically diverse population, as well as a multitude of...
